The Natural Progression of Parkinson’s Disease in a Small Cohort with 15 Drug-na?ve Patients

被引:0
|
作者
Liu Ying
Fan Jin-Hu
Gao Xiang
Ma Li
Qiao You-Lin
Zhang Lin
机构
[1] USA
[2] Chinese Academy of Medical Sciences and Peking Union Medical College
[3] Dalian Municipal Friendship Hospital
[4] Boston
[5] Cancer Hospital
[6] and Harvard Medical School
[7] China
[8] MA 02115
[9] Brigham and Women’s Hospital
[10] Channing Laboratory
[11] Liaoning 116001
[12] CA 95817
[13] University of California Davis School of Medicine
[14] Department of Nutrition
[15] Harvard University School of Public Health
[16] Department of Neurology
[17] Department of Cancer Epidemiology
[18] Department of Medicine
[19] Sacramento
[20] Beijing 100021
关键词
Drug-na?ve; Epidemiology; Parkinson’s Disease; Progression;
D O I
暂无
中图分类号
R742.5 [震颤麻痹综合征];
学科分类号
1002 ;
摘要
Background: The studies of the natural progression of Parkinson’s disease (PD) in Chinese populations have been lacking. To address this issue and obtain a preliminary data, we conducted a PD progression assessment in 15 adults withde novo PD from a nutritional intervention trial (NIT) cohort in Lin County China.Methods: Using the Copiah County screening questionnaire and United Kingdom Parkinson’s Disease Society Brain Bank diagnostic criteria, we surveyed the available NIT cohort members in 2000 and diagnosed 86 patients as PD. In 2010, we resurveyed all PD patients and confirmed definite PD diagnosis in 15 cases with the rest of them being dead (54); having probable (10) PD or vascular Parkinsonism (3); refusing to participate (2); or being away (2). In both surveys, we used Hoehn and Yahr (HY) scale and assessed the disease progression. Unified Parkinson’s Disease Rating Scale (UPDRS) was added to the second survey.Results: In 2010, the average disease duration for 15 definite PD patients was 13.6 ± 7.3 years. Over a 10-year time span, 9 out of 15 patients remained at the same HY stage while the remaining 6 progressed. Rigidity (47% vs. 100%;P = 0.002) and postural instability (7% vs. 47%;P = 0.005) worsened significantly. The mean UPDRS motor scores in 2010 were 39.4 ± 23.7.Conclusions: Overall worsening of motor function in PD seems to be the rule in this untreated cohort, and their rate of progression seemed to be slower than those reported in the western populations.
引用
收藏
页码:1761 / 1764
页数:4
相关论文
共 50 条
  • [1] The Natural Progression of Parkinson's Disease in a Small Cohort with 15 Drug-naive Patients
    Liu, Ying
    Fan, Jin-Hu
    Gao, Xiang
    Ma, Li
    Qiao, You-Lin
    Zhang, Lin
    CHINESE MEDICAL JOURNAL, 2015, 128 (13) : 1761 - 1764
  • [2] Blood transcriptomics of drug-naïve sporadic Parkinson’s disease patients
    Raffaella Calligaris
    Mihaela Banica
    Paola Roncaglia
    Elisa Robotti
    Sara Finaurini
    Christina Vlachouli
    Lucia Antonutti
    Francesco Iorio
    Annamaria Carissimo
    Tatiana Cattaruzza
    Andrea Ceiner
    Dejan Lazarevic
    Alberto Cucca
    Nicola Pangher
    Emilio Marengo
    Diego di Bernardo
    Gilberto Pizzolato
    Stefano Gustincich
    BMC Genomics, 16
  • [3] Apathy in drug-na⟨ve patients with incident Parkinson's disease: the Norwegian ParkWest study
    Pedersen, Kenn Freddy
    Alves, Guido
    Bronnick, Kolbjorn
    Aarsland, Dag
    Tysnes, Ole-Bjorn
    Larsen, Jan Petter
    JOURNAL OF NEUROLOGY, 2010, 257 (02) : 217 - 223
  • [4] A metabolomic signature of treated and drug-naïve patients with Parkinson’s disease: a pilot study
    Jacopo Troisi
    Annamaria Landolfi
    Carmine Vitale
    Katia Longo
    Autilia Cozzolino
    Massimo Squillante
    Maria Cristina Savanelli
    Paolo Barone
    Marianna Amboni
    Metabolomics, 2019, 15
  • [5] Apathy in drug-naïve patients with incident Parkinson’s disease: the Norwegian ParkWest study
    Kenn Freddy Pedersen
    Guido Alves
    Kolbjørn Brønnick
    Dag Aarsland
    Ole-Bjørn Tysnes
    Jan Petter Larsen
    Journal of Neurology, 2010, 257 : 217 - 223
  • [6] Serum uric acid is associated with apathy in early, drug-na⟨ve Parkinson's disease
    Picillo, Marina
    Santangelo, Gabriella
    Moccia, Marcello
    Erro, Roberto
    Amboni, Marianna
    Prestipino, Elio
    Longo, Katia
    Vitale, Carmine
    Spina, Emanuele
    Orefice, Giuseppe
    Barone, Paolo
    Pellecchia, Maria Teresa
    JOURNAL OF NEURAL TRANSMISSION, 2016, 123 (04) : 371 - 377
  • [7] The association between urinary pentosidine levels and cognition in drug-naïve patients with Parkinson’s disease
    Shusaku Omoto
    Mitsuru Saito
    Hidetomo Murakami
    Tomotaka Shiraishi
    Tomomichi Kitagawa
    Takeo Sato
    Hiroki Takatsu
    Teppei komatsu
    Kenichiro Sakai
    Tadashi Umehara
    Hidetaka Mitsumura
    Yasuyuki Iguchi
    Neurological Sciences, 2022, 43 : 6323 - 6328
  • [8] Face pareidolia is associated with right striatal dysfunction in drug-naïve patients with Parkinson’s disease
    Hidetomo Murakami
    Tomotaka Shiraishi
    Tadashi Umehara
    Shusaku Omoto
    Maki Takahashi
    Haruhiko Motegi
    Takahiro Maku
    Takeo Sato
    Hiroki Takatsu
    Teppei Komatsu
    Keiko Bono
    Kenichiro Sakai
    Hidetaka Mitsumura
    Yasuyuki Iguchi
    Neurological Sciences, 2021, 42 : 5327 - 5334
  • [9] Putamen dopaminergic dysfunction is associated with sleep disturbance in drug-naïve patients with Parkinson's disease
    Ozawa, Masakazu
    Murakami, Hidetomo
    Muraoka, Yuichiro
    Ibukuro, Momoyo
    Shiraishi, Tomotaka
    Onda, Asako
    Matsuno, Hiromasa
    Bono, Keiko
    Umehara, Tadashi
    Omoto, Shusaku
    Okano, Hirotaka James
    Iguchi, Yasuyuki
    SLEEP MEDICINE, 2025, 129 : 82 - 88
  • [10] Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson’s disease
    Marina Picillo
    Roberto Erro
    Gabriella Santangelo
    Rosario Pivonello
    Katia Longo
    Claudia Pivonello
    Carmine Vitale
    Marianna Amboni
    Marcello Moccia
    Annamaria Colao
    Paolo Barone
    Maria Teresa Pellecchia
    Journal of Neurology, 2013, 260 : 1724 - 1730